Cost-Utility Analysis of Paclitaxel in Combination with Cisplatin for Patients with Advanced Ovarian Cancer

By Ortega A.   Dranitsaris G.   Sturgeon J.   Sutherland H.   Oza A.  

Gynecologic Oncology, Vol. 66, Iss. 3, 1997-09 ,pp. : 454-463

Elsevier

Access to resources Recommend Favorite

Cisplatin-Paclitaxel-Cyclophosphamide with G-CSF in Primary Advanced Epithelial Ovarian Cancer

By Fanning J.   Colgrove M.   Phibbs G.  

Gynecologic Oncology, Vol. 79, Iss. 1, 2000-10 ,pp. : 97-100

Elsevier

Access to resources Recommend Favorite

Phase I Trial of Carboplatin, Paclitaxel, Etoposide, and Cyclophosphamide with Granulocyte Colony Stimulating Factor as First-Line Therapy for Patients with Advanced Epithelial Ovarian Cancer

By Tung N.   Berkowitz R.   Matulonis U.   Quartulli M.   Seiden M.   Kim Y.   Niloff J.   Cannistra S.A.  

Gynecologic Oncology, Vol. 77, Iss. 2, 2000-05 ,pp. : 271-277

Elsevier

Access to resources Recommend Favorite

A Phase I/II Study of Dose-Intense Paclitaxel with Cisplatin and Cyclophosphamide as Initial Therapy of Poor-Prognosis Advanced-Stage Epithelial Ovarian Cancer

By Kohn E.C.   Sarosy G.A.   Davis P.   Christian M.   Link C.E.   Ognibene F.P.   Sindelar W.F.   Jacob J.   Steinberg S.M.   Premkumar A.   Reed E.  

Gynecologic Oncology, Vol. 62, Iss. 2, 1996-08 ,pp. : 181-191

Academic Press

Access to resources Recommend Favorite

Randomized Study Comparing Carboplatin/Cyclophosphamide and Cisplatin/Cyclophosphamide as First-Line Treatment in Patients with Stage III/IV Epithelial Ovarian Cancer and Small Volume Disease

By Meerpohl H.G.   Sauerbrei W.   Kuhnle H.   Schumacher M.   Pfleiderer A.   German Ovarian Cancer Study Group GOCA  

Gynecologic Oncology, Vol. 66, Iss. 1, 1997-07 ,pp. : 75-84

Elsevier

Access to resources Recommend Favorite